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Abstract
Severe sepsis is a major concern in the intensive care unit (ICU), although there is very little epidemiological
information regarding severe sepsis in Japan. This study evaluated 3195 patients with severe sepsis in 42 ICUs
throughout Japan. The patients with severe sepsis had a mean age of 70 ± 15 years and a mean Acute Physiology
and Chronic Health Evaluation II score of 23 ± 9. The estimated survival rates at 28 and 90 days after ICU admission
were 73.6 and 56.3 %, respectively.
Keywords: Severe sepsis, Mortality, Epidemiology, Acute respiratory failure, Acute kidney injury, Disseminated
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Background
Many recent multicenter epidemiological studies have
evaluated sepsis [1–7], although there is very little
information regarding its epidemiology in Japan [1, 2].
Despite the limited amount of Japanese information, epi-
demiological data regarding severe sepsis are important
for guiding clinical practice and the design of clinical
studies. Therefore, the present study aimed to retro-
spectively evaluate a large population of patients with
severe sepsis in intensive care units (ICUs) throughout
Japan.
Methods
The present study analyzed the unlinkable anonymized
database of the Japan Septic Disseminated Intravascular
Coagulation (JSEPTIC DIC) study [8]. Cases of shock,
respiratory failure, or renal failure were defined as
patients with a cardiovascular, respiratory, or renal
Sequential Organ Failure Assessment (SOFA) score of
≥4 on day 1 [9]. Cases of disseminated intravascular co-
agulation (DIC) were defined as patients with a Japanese
Association for Acute Medicine DIC score of ≥4 on
day 1. All data were expressed as number (percent),
mean ± standard deviation, or median (interquartile
range), as appropriate. Survival rates were evaluated
using the Kaplan-Meier method. All analyses were
performed using SPSS software (version 22; SPSS Inc.,
Chicago, IL).
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Results
The present study included 3195 consecutive patients
(2111 patients without shock and 1084 patients with
shock). These patients included 1916 men (mean age 68
± 14 years) and 1279 women (mean age 71 ± 15 years).
The mean Acute Physiology and Chronic Health Evalu-
ation II score among all patients was 23 ± 9. The primary
infection sites are presented in Table 1. The blood cul-
ture results and responsible microorganisms are pre-
sented in Table 2. The frequencies of administering
various adjunct treatments for severe sepsis during the
first 7 days after ICU admission are shown in Table 3.
The survival curves for patients with and without vari-
ous medical conditions are presented in Fig. 1. The esti-
mated survival rates at 28 and 90 days among all
patients with severe sepsis after the ICU admission were
73.6 and 56.3 %, respectively.
Discussion
The present study evaluated the characteristics, treat-
ments, and outcomes from 3195 patients with severe
sepsis in 42 ICUs throughout Japan. The earlier epi-
demiological reports from after 2005 are summarized in
the Additional file 1: Table S1. Although two previous
Japanese studies have reported epidemiological informa-
tion from 890 Japanese patients with severe sepsis, most
of the participating institutions were university hospitals
[1, 2]. In contrast, approximately half of the participating
institutions in the present study were municipal hospi-
tals. Furthermore, we included both general and emer-
gency ICUs. Nevertheless, the distributions of age,
severity, and mortality rates in the present study were
similar to the findings from two previous Japanese
studies [1, 2].
Patients with severe sepsis in other countries are gen-
erally younger than their Japanese counterparts [1–7].
Furthermore, other countries have higher mortality rates
for patients with severe sepsis, compared to the rate
from the present study, although the Acute Physiology
and Chronic Health Evaluation II scores are similar for
Japanese patients and other patients with sepsis [1–7].
However, the reports from the other countries evaluated
patients with sepsis during an earlier period (2002–
2010), compared to the patients from the three Japanese
reports (2007–2013) [1–7]. Furthermore, mortality
among patients with sepsis has decreased on an annual
basis, and these factors may explain the different mortal-
ity rates in Japan and other countries.
The present study’s mortality rates for severe sepsis
with and without shock are similar to the results from
previous Japanese studies [1, 2]. However, severe sepsis
is frequently complicated by respiratory failure, renal
Table 1 Primary infection site responsible for the sepsis
Without shock With shock Total
n = 2111 n = 1084 n = 3195
Abdomen 661 (31 %) 371 (34 %) 1032 (32 %)
Lung/thorax 575 (27 %) 252 (23 %) 827 (26 %)
Urinary tract 349 (17 %) 160 (15 %) 509 (16 %)
Bone/soft tissue 251 (12 %) 123 (11 %) 374 (12 %)
Cardiovascular system 54 (3 %) 14 (1 %) 68 (2 %)
Central nervous system 44 (2 %) 19 (2 %) 63 (2 %)
Catheter-related 23 (1 %) 21 (2 %) 44 (1 %)
Other 37 (2 %) 23 (2 %) 60 (2 %)
Unknown 117 (6 %) 101 (9 %) 218 (7 %)
Data are expressed as number (percent)
Table 2 Microorganisms responsible for the sepsis and blood
culture results
Without shock With shock Total
n = 2111 n = 1084 n = 3195
Microorganisms responsible for the sepsis
Gram-negative rod 774 (35%) 421 (39%) 1165 (37%)
Gram-positive coccus 477 (23%) 261 (24%) 738 (23%)
Fungus 43 (2%) 14 (1%) 57 (2%)
Virus 20 (1%) 8 (1%) 28 (1%)
Mixed infection 254 (12%) 146 (14%) 400 (13%)
Other 40 (2%) 18 (2%) 58 (2%)
Unknown 533 (25%) 216 (20%) 749 (23%)
Blood culture
Positive 866 (41%) 540 (50%) 1406 (44%)
Negative 1,083 (51%) 508 (47%) 1591 (50%)
Not taken 162 (8%) 36 (3%) 198 (6%)
Data are expressed as number (percent)
Table 3 Frequencies of various adjunct treatments for severe






Co-administration of antithrombin and
thrombomodulin
496 (16%)
Protease inhibitors 392 (12%)
Heparinoids 167 (5%)
Immunoglobulin 976 (31%)
Low-dose steroids 777 (24%)
Renal replacement therapy 890 (28%)
Non-renal indication renal replacement therapy 266 (8%)
Polymyxin B-direct hemoperfusion 692 (22%)
Data are presented as number (percentage)
DIC disseminated intravascular coagulation, ICU intensive care unit
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failure, and DIC [10], and the previous studies did not
evaluate the mortality rates for severe sepsis in cases
with respiratory or renal failure [1, 2]. Thus, the present
study provides the first survival curve data for Japanese
patients with severe sepsis according to their complica-
tions with shock, respiratory failure, renal failure, or
DIC.
Additional file
Additional file 1: Table S1. Epidemiological information from previous
reports after 2005. (DOC 48 kb)
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Fig. 1 Survival curves for patients with and without various medical conditions. The patients with medical conditions exhibited a poorer survival
rate, compared to the patients without the conditions. Cases of shock, respiratory failure, or renal failure were defined as a cardiovascular,
respiratory, or renal Sequential Organ Failure Assessment (SOFA) score of ≥4 on day 1. Cases of disseminated intravascular coagulation (DIC) were
defined as a DIC score of ≥4 on day 1
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